Voglibose administration regulates body weight and energy intake in high fat-induced obese mice

Hyun Ju Do, Taeon Jin, Ji Hyung Chung, Ji Won Hwang, Min-Jeong Shin

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We tested whether long-term administration of voglibose (VO) prevents diet induced obesity in addition to hypoglycemic effects in high fat fed mice and further investigated the underlying mechanisms by which voglibose exerts its weight lowering effect. Male C57BL/6 mice were fed ad libitum for 12 weeks with the control diet (CTL), high-fat diet (HFD) or the HFD with VO supplementations. Blood lipid profile, plasma leptin levels and hepatic triglyceride content, as well as expressions of genes involved in appetite and mitochondrial function were examined. The results showed that VO significantly reduced body weight, fat mass and energy intakes in high fat fed mice. VO showed improved metabolic profiles including blood glucose, triglyceride and free fatty acid. Elevated levels of plasma leptin in HFD were significantly reduced with the VO, furthermore, VO modulated the hypothalamic expressions of leptin receptors and appetite related genes. VO showed the upregulated expressions of PGC-1 in the liver and epididymal adipose tissue. In conclusion, VO may exert antiobesity properties through reductions in energy intake and improvement in mitochondrial function, indicating that VO has potential therapeutic use in patients with obesity, type 2 diabetes, and related complications.

Original languageEnglish
Pages (from-to)1110-1117
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume443
Issue number3
DOIs
Publication statusPublished - 2014 Jan 17

Fingerprint

Obese Mice
Energy Intake
Fats
Body Weight
Nutrition
High Fat Diet
Appetite
Leptin
Triglycerides
Obesity
Genes
voglibose
Diet
Plasmas
Leptin Receptors
Metabolome
Liver
Therapeutic Uses
Diabetes Complications
Medical problems

Keywords

  • Appetite
  • Leptin
  • Leptin receptor
  • Mitochondria
  • Obesity
  • PGC1
  • Voglibose

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Voglibose administration regulates body weight and energy intake in high fat-induced obese mice. / Do, Hyun Ju; Jin, Taeon; Chung, Ji Hyung; Hwang, Ji Won; Shin, Min-Jeong.

In: Biochemical and Biophysical Research Communications, Vol. 443, No. 3, 17.01.2014, p. 1110-1117.

Research output: Contribution to journalArticle

@article{97b788581030478c86b5f6b0fdd5d85b,
title = "Voglibose administration regulates body weight and energy intake in high fat-induced obese mice",
abstract = "We tested whether long-term administration of voglibose (VO) prevents diet induced obesity in addition to hypoglycemic effects in high fat fed mice and further investigated the underlying mechanisms by which voglibose exerts its weight lowering effect. Male C57BL/6 mice were fed ad libitum for 12 weeks with the control diet (CTL), high-fat diet (HFD) or the HFD with VO supplementations. Blood lipid profile, plasma leptin levels and hepatic triglyceride content, as well as expressions of genes involved in appetite and mitochondrial function were examined. The results showed that VO significantly reduced body weight, fat mass and energy intakes in high fat fed mice. VO showed improved metabolic profiles including blood glucose, triglyceride and free fatty acid. Elevated levels of plasma leptin in HFD were significantly reduced with the VO, furthermore, VO modulated the hypothalamic expressions of leptin receptors and appetite related genes. VO showed the upregulated expressions of PGC-1 in the liver and epididymal adipose tissue. In conclusion, VO may exert antiobesity properties through reductions in energy intake and improvement in mitochondrial function, indicating that VO has potential therapeutic use in patients with obesity, type 2 diabetes, and related complications.",
keywords = "Appetite, Leptin, Leptin receptor, Mitochondria, Obesity, PGC1, Voglibose",
author = "Do, {Hyun Ju} and Taeon Jin and Chung, {Ji Hyung} and Hwang, {Ji Won} and Min-Jeong Shin",
year = "2014",
month = "1",
day = "17",
doi = "10.1016/j.bbrc.2013.12.120",
language = "English",
volume = "443",
pages = "1110--1117",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Voglibose administration regulates body weight and energy intake in high fat-induced obese mice

AU - Do, Hyun Ju

AU - Jin, Taeon

AU - Chung, Ji Hyung

AU - Hwang, Ji Won

AU - Shin, Min-Jeong

PY - 2014/1/17

Y1 - 2014/1/17

N2 - We tested whether long-term administration of voglibose (VO) prevents diet induced obesity in addition to hypoglycemic effects in high fat fed mice and further investigated the underlying mechanisms by which voglibose exerts its weight lowering effect. Male C57BL/6 mice were fed ad libitum for 12 weeks with the control diet (CTL), high-fat diet (HFD) or the HFD with VO supplementations. Blood lipid profile, plasma leptin levels and hepatic triglyceride content, as well as expressions of genes involved in appetite and mitochondrial function were examined. The results showed that VO significantly reduced body weight, fat mass and energy intakes in high fat fed mice. VO showed improved metabolic profiles including blood glucose, triglyceride and free fatty acid. Elevated levels of plasma leptin in HFD were significantly reduced with the VO, furthermore, VO modulated the hypothalamic expressions of leptin receptors and appetite related genes. VO showed the upregulated expressions of PGC-1 in the liver and epididymal adipose tissue. In conclusion, VO may exert antiobesity properties through reductions in energy intake and improvement in mitochondrial function, indicating that VO has potential therapeutic use in patients with obesity, type 2 diabetes, and related complications.

AB - We tested whether long-term administration of voglibose (VO) prevents diet induced obesity in addition to hypoglycemic effects in high fat fed mice and further investigated the underlying mechanisms by which voglibose exerts its weight lowering effect. Male C57BL/6 mice were fed ad libitum for 12 weeks with the control diet (CTL), high-fat diet (HFD) or the HFD with VO supplementations. Blood lipid profile, plasma leptin levels and hepatic triglyceride content, as well as expressions of genes involved in appetite and mitochondrial function were examined. The results showed that VO significantly reduced body weight, fat mass and energy intakes in high fat fed mice. VO showed improved metabolic profiles including blood glucose, triglyceride and free fatty acid. Elevated levels of plasma leptin in HFD were significantly reduced with the VO, furthermore, VO modulated the hypothalamic expressions of leptin receptors and appetite related genes. VO showed the upregulated expressions of PGC-1 in the liver and epididymal adipose tissue. In conclusion, VO may exert antiobesity properties through reductions in energy intake and improvement in mitochondrial function, indicating that VO has potential therapeutic use in patients with obesity, type 2 diabetes, and related complications.

KW - Appetite

KW - Leptin

KW - Leptin receptor

KW - Mitochondria

KW - Obesity

KW - PGC1

KW - Voglibose

UR - http://www.scopus.com/inward/record.url?scp=84893638847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893638847&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2013.12.120

DO - 10.1016/j.bbrc.2013.12.120

M3 - Article

VL - 443

SP - 1110

EP - 1117

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 3

ER -